GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Book Value per Share

Biovica International AB (OSTO:BIOVIC B) Book Value per Share : kr0.66 (As of Jan. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Book Value per Share?

Biovica International AB's book value per share for the quarter that ended in Jan. 2025 was kr0.66.

During the past 12 months, Biovica International AB's average Book Value Per Share Growth Rate was -59.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -43.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -14.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Biovica International AB was 107.00% per year. The lowest was -43.50% per year. And the median was 13.70% per year.

Biovica International AB's current price is kr0.764. Its book value per share for the quarter that ended in Jan. 2025 was kr0.66. Hence, today's PB Ratio of Biovica International AB is 1.16.

During the past 10 years, the highest P/B Ratio of Biovica International AB was 13.23. The lowest was 1.05. And the median was 2.82.

Good Sign:

Biovica International AB stock PB Ratio (=1.16) is close to 10-year low of 1.05.


Biovica International AB Book Value per Share Historical Data

The historical data trend for Biovica International AB's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Book Value per Share Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.28 6.39 4.31 3.03 1.15

Biovica International AB Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.62 1.15 1.06 0.89 0.66

Competitive Comparison of Biovica International AB's Book Value per Share

For the Biotechnology subindustry, Biovica International AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's PB Ratio distribution charts can be found below:

* The bar in red indicates where Biovica International AB's PB Ratio falls into.


;
;

Biovica International AB Book Value per Share Calculation

Biovica International AB's Book Value Per Share for the fiscal year that ended in Apr. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(96.64-0.00)/84.06
=1.15

Biovica International AB's Book Value Per Share for the quarter that ended in Jan. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(64.46-0.00)/97.79
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Biovica International AB  (OSTO:BIOVIC B) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Biovica International AB Book Value per Share Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB Business Description

Traded in Other Exchanges
N/A
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. The company develops and commercializes blood-based diagnostic tests with biomarkers that improve the monitoring and evaluation of modern cancer treatments. The company promotes healthcare through collaboration with cancer institutes and pharmaceutical companies. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB Headlines

No Headlines